ModiQuest
Research, the full service provider for antibody generation,
engineering and optimization, has successfully generated novel antibody
therapeutic leads and diagnostics for rheumatoid arthritis (RA). Using
its extensive antibody generation technology platform, which includes
phage display and high throughput mouse hybridoma generation, the
company identified specific anti-citrulline antibodies that demonstrate
high efficacy levels in preclinical RA models.
The company has been especially successful in supporting a variety of autoimmune disease projects in addition to rheumatoid arthritis, including multiple sclerosis, and lupus
erythematosus. By using a combination of a unique technology service
platform and a growing collection of immunological reagents for
autoimmune disease research, ModiQuest provides the antibody expertise,
as well as customised antigens, monoclonal antibodies and enzymes specifically designed for early diagnosis as well as therapeutic research.
http://www.modiquestresearch.com/products-page/autoimmune-bioreagents/ Research
scientists at ModiQuest Research have definitive expertise in
autoimmune disease allowing them to provide deep insights drawn from
their own extensive experience in the field, and an unrivalled suite of
products and services specifically aimed at supporting autoimmune
disease research. Examples of autoimmune products and services that ModiQuest
Research provides include: an effective mix of anti-collagen monoclonal
antibodies for generating collagen antibody-induced arthritis (CAIA) in
mice; readily available ELISA assay kits for evaluating
autoimmune-associated peptide de-imination; custom
development of diagnostic assays for other autoimmune disease pathways,
and bespoke arthritis preclinical mouse efficacy studies for analyzing
the therapeutic effects of client compounds in rheumatoid arthritis
mouse models.
"We have demonstrable success in generating anti-collagen
antibody products for rheumatoid arthritis research and we have huge
experience in the area of auto-immune and inflammatory disease" said Dr
Jos Raats CEO of ModiQuest Research. "We are currently helping a number
of companies potentiate autoimmune therapies and diagnostic kits by the
application of our antibody products and expertise."
ModiQuest
Research, which was established in 2005, has extensive knowledge and
experience of antibody technologies. With its state-of-the-art
facilities, proprietary technology and end-to-end support services,
ModiQuest Research is superbly placed to support the development and
production of antibody-based therapies and diagnostics in the most
efficient and cost effective way possible. If you are active in
autoimmune research then Modiquest Research can help you maximize the
potential of your project.
Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!
Request your free copies HERE
Popular this Month
Top 10 most popular articles this month
Today's Picks
Looking for a Supplier?
Search by company or by product
Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.
Lab Bulletin is published by newleaf marketing communications ltd.